Helen and Jacob Shaham pledged $30 million to FIU Medicine, and the university will name its new on-campus academic medical center in their honor. The gift aims to expand scholarships, research and outpatient services at a facility slated for 2028.

Wasabi has closed its acquisition of Seagate’s Lyve Cloud, folding the S3‑compatible platform into its hot‑cloud stack and accelerating its push into AI‑ready storage.

Ampera opened a Palm Beach Gardens HQ and factory to build container‑sized, thorium microreactors it calls "ultra‑safe." The company promises jobs and is now pursuing NRC pre‑application.

Experts warned AI could bring big jobs and investment to Dallas‑Fort Worth while testing power, water and workforce capacity across the region.

Indiana University physicians were co‑authors on a NEJM trial showing enfortumab vedotin plus pembrolizumab produced large survival gains for certain bladder cancer patients. IU sites helped enroll and analyze the data behind the finding.

Researchers at the University of Miami are testing stem‑cell strategies to replace neurons lost in Parkinson’s disease; early lab and trial signals offer cautious hope.

Axiom Space is assembling the AxEMU lunar suits in Houston — seamstresses and engineers are running pools and vacuum tests as NASA moves toward Artemis surface operations.

Stanford Medicine has installed a compact Mevion proton system at its Palo Alto Cancer Center that hospital leaders say could begin treating patients this summer and reduce radiation to healthy tissue.

Life Biosciences closed an $80M Series D to fund a first-in-human ER-100 trial and expand its partial epigenetic reprogramming pipeline.

The FBI's IC3 warns foreign-developed apps can access contacts and other device data — even for people who never installed the app. Experts and local outlets name Temu, CapCut and SHEIN as examples.

A federal judge found a customs officer wrongly revoked a Harvard researcher's visa after frog-embryo samples were found at Logan Airport, a decision with wide implications.

A thaw in the IPO market has Chicago founders and bankers rethinking long‑delayed exits and liquidity plans for employees and investors. Local deal activity could follow.

Iovance’s Navy Yard plant turns tumors into Amtagvi, the first FDA-approved TIL therapy for melanoma, creating jobs and raising access questions.